Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Double-blind, Sham-controlled Multi-center Clinical Study Assessing the Safety and Efficacy of Nerivio for the Preventive Treatment of Migraine

NCT04828707 is registered in ClinicalTrials.gov with Theranica as lead sponsor.

NCT NCT04828707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04828707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Double-blind, Sham-controlled Multi-center Clinical Study Assessing the Safety and Efficacy of Nerivio for the Preventive Treatment of Migraine
Lead sponsor
Theranica
Phase
Not applicable
Overall status
Completed
Start date
April 13, 2021
Completion date
October 10, 2022
Enrollment
335 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

migraine